Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;121(1):76-85.
doi: 10.1038/s41416-019-0476-8. Epub 2019 May 22.

A systematic review and quality assessment of individualised breast cancer risk prediction models

Affiliations

A systematic review and quality assessment of individualised breast cancer risk prediction models

Javier Louro et al. Br J Cancer. 2019 Jul.

Abstract

Background: Individualised breast cancer risk prediction models may be key for planning risk-based screening approaches. Our aim was to conduct a systematic review and quality assessment of these models addressed to women in the general population.

Methods: We followed the Cochrane Collaboration methods searching in Medline, EMBASE and The Cochrane Library databases up to February 2018. We included studies reporting a model to estimate the individualised risk of breast cancer in women in the general population. Study quality was assessed by two independent reviewers. Results are narratively summarised.

Results: We included 24 studies out of the 2976 citations initially retrieved. Twenty studies were based on four models, the Breast Cancer Risk Assessment Tool (BCRAT), the Breast Cancer Surveillance Consortium (BCSC), the Rosner & Colditz model, and the International Breast Cancer Intervention Study (IBIS), whereas four studies addressed other original models. Four of the studies included genetic information. The quality of the studies was moderate with some limitations in the discriminative power and data inputs. A maximum AUROC value of 0.71 was reported in the study conducted in a screening context.

Conclusion: Individualised risk prediction models are promising tools for implementing risk-based screening policies. However, it is a challenge to recommend any of them since they need further improvement in their quality and discriminatory capacity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flowchart
Fig. 2
Fig. 2
Area under the ROC curve (AUROC) and Confidence Intervals reported by the included studies. a AUROC values reported by the BCRAT model studies. b AUROC values reported by the BCSC model studies. c AUROC values reported by the Rosner & Colditz model studies. d AUROC values reported by other original models
Fig. 3
Fig. 3
Risk of bias summary: review authors’ judgments about each risk of bias item for each included study. a Review authors’ judgments presented as percentages across all included studies. b Risk of bias summary for the studies that reported the BCRAT model studies. c Risk of bias summary for the studies that reported the BCSC model studies. d Risk of bias summary for the studies that reported the Rosner & Colditz model studies. e Risk of bias summary for the studies that reported other original models

References

    1. The Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 380, 1778–1786 (2012). - PubMed
    1. The European Commission Initiative on Breast Cancer (ECIBC). Recommendations from European Breast Guidelines. 2016. https://ecibc.jrc.ec.europa.eu/recommendations/.
    1. Force USPST.. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern Med. 2009;151:716–726. doi: 10.7326/0003-4819-151-10-200911170-00008. - DOI - PubMed
    1. Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314:1599–1614. doi: 10.1001/jama.2015.12783. - DOI - PMC - PubMed
    1. Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, et al. Collaborative modeling of the benefits and harms associated with different U.S. Breast Cancer Screening Strategies. Ann. Intern Med. 2016;164:215–225. doi: 10.7326/M15-1536. - DOI - PMC - PubMed

Publication types